UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| 1 |
Alibaba
BABA
|
+$2.55B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$459M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$316M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$293M |
| 5 |
GSK
GSK
|
+$251M |
Top Sells
| 1 |
Stellantis
STLA
|
+$991M |
| 2 |
Microsoft
MSFT
|
+$408M |
| 3 |
Apple
AAPL
|
+$315M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$296M |
| 5 |
Intel
INTC
|
+$283M |
Sector Composition
| 1 | Technology | 14.92% |
| 2 | Consumer Discretionary | 9.1% |
| 3 | Financials | 8.49% |
| 4 | Healthcare | 7.86% |
| 5 | Industrials | 6.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KRTX
3801
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $600K | ﹤0.01% |
4,989
+4,285
| +609% | +$515K |
|
3802
ProQR Therapeutics
PRQR
$221M
| $599K | ﹤0.01% |
90,615
-381,488
| -81% | -$2.52M |
|
|
SVM
3803
Silvercorp Metals
SVM
$1.14B
| $598K | ﹤0.01% |
121,798
-55,400
| -31% | -$272K |
|
3804
Acuity Brands
AYI
$10.3B
| $597K | ﹤0.01% |
3,620
+1,697
| +88% | +$280K |
|
3805
Axogen
AXGN
$791M
| $596K | ﹤0.01% |
29,433
+6,200
| +27% | +$126K |
|
|
CTT
3806
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $596K | ﹤0.01% |
58,562
+43,044
| +277% | +$438K |
|
3807
Stoke Therapeutics
STOK
$1.25B
| $595K | ﹤0.01% |
+15,315
| New | +$595K |
|
3808
SPDR S&P Telecom ETF
XTL
$158M
| $594K | ﹤0.01% |
6,330
+271
| +4% | +$25.4K |
|
3809
Copa Holdings
CPA
$4.93B
| $593K | ﹤0.01% |
7,341
-15,503
| -68% | -$1.25M |
|
|
AVYA
3810
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $593K | ﹤0.01% |
21,149
-7,773
| -27% | -$218K |
|
3811
AppFolio
APPF
$10.1B
| $592K | ﹤0.01% |
4,182
+1,557
| +59% | +$220K |
|
|
NIU
3812
Niu Technologies
NIU
$336M
| $592K | ﹤0.01% |
16,162
+4,792
| +42% | +$176K |
|
|
AFIB
3813
DELISTED
Acutus Medical, Inc. Common Stock
AFIB
| $592K | ﹤0.01% |
44,259
+16,323
| +58% | +$218K |
|
3814
Arcutis Biotherapeutics
ARQT
$2.08B
| $591K | ﹤0.01% |
+20,446
| New | +$591K |
|
3815
Northfield Bancorp
NFBK
$487M
| $590K | ﹤0.01% |
37,107
-12,372
| -25% | -$197K |
|
3816
Great Southern Bancorp
GSBC
$712M
| $587K | ﹤0.01% |
10,356
+3,616
| +54% | +$205K |
|
3817
Global Water Resources
GWRS
$274M
| $582K | ﹤0.01% |
35,688
-523
| -1% | -$8.53K |
|
3818
Inogen
INGN
$234M
| $582K | ﹤0.01% |
11,087
-23,100
| -68% | -$1.21M |
|
3819
Manchester United
MANU
$2.6B
| $582K | ﹤0.01% |
36,952
+1,109
| +3% | +$17.5K |
|
|
SOGP
3820
Sound Group
SOGP
$98.2M
| $582K | ﹤0.01% |
6,358
+6,110
| +2,464% | +$559K |
|
3821
Aldeyra Therapeutics
ALDX
$296M
| $581K | ﹤0.01% |
48,907
-53,473
| -52% | -$635K |
|
3822
Andersons Inc
ANDE
$1.32B
| $580K | ﹤0.01% |
21,179
-5,909
| -22% | -$162K |
|
3823
SuRo Capital
SSSS
$219M
| $578K | ﹤0.01% |
50,784
+26,512
| +109% | +$302K |
|
3824
Capital Southwest
CSWC
$1.29B
| $577K | ﹤0.01% |
26,018
+9,456
| +57% | +$210K |
|
|
VGI
3825
Virtus Global Multi-Sector Income Fund
VGI
$90.1M
| $577K | ﹤0.01% |
48,596
+2,546
| +6% | +$30.2K |
|